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Abstract 
The present review attempted to emphasize on the microbiological quality of the commonly used cosmetics item 
by the majority of the Bangladeshi community. The abundance of contaminating microorganisms has been quanti-
tatively discussed and the possible health risk has been focused upon usage of these items. Only a very few research 
efforts have been conducted on the cosmetic items in Bangladesh so far. The microbiological contamination aspects 
have been portrayed in this review using the information collected from a substantial number of cosmetic items 
which were earlier subjected to extensive microbiological and biochemical analyses. The prevalence of bacteria, fungi 
and the specific pathogenic microorganisms has been discussed based on research so far locally conducted on the 
finished items sold in markets, especially within the Dhaka metropolis. The laboratory scale experiments revealed the 
presence of enormous number of bacteria, actinomycetes and fungi within the commonly used cosmetics. Con-
versely, the anti-bacterial activity was noticed in some of the products which might be in favor of the user safety. The 
prevalence of pathogenic microorganisms in the cosmetic items certainly raises a substantial public health issue. The 
necessity of the routine microbiological testing of the commonly used cosmetic items as well as the legislative meas-
ures to mitigate the contamination problem is thus of great significance.
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Background
Cosmetic items have long been used by the people 
around the world in order to enhance personal appear-
ance and maintain personal hygiene and safety [1–5]. 
Varieties of cosmetics with discrete functions are cur-
rently available (they are being used for the care of each 
part of body) [6–8]. Thus, the cosmetic items are the 
principal categories of health care products besides the 
pharmaceutical products which are mainly used for miti-
gation of diseases [6–8]. The cosmetic items are in gen-
eral known as the chemical substances or sometimes the 
preparations from natural herbs which are frequently 
applied to human body exclusively with an intention of 
beautification as well as for cleaning and protection from 
various hazards [1, 2, 9, 10]. Besides the chemical reactiv-
ity or the side effects of cosmetic usage, another aspect 
of discussion relies on the microbiological quality of the 
cosmetic products [2, 11]. Though the cosmetic items are 
considered principally as the health care products, since 
they are largely under the non-sterile pharmaceutical cat-
egories, the items may undergo microbial contamination 
[2, 12–14]. The extent of microbial contamination largely 
depends on the microorganism-infected bulk ingredients 
during product manufacturing and processing accom-
panied with insufficient in-process quality examinations 
followed by unfussy storage condition as well as the dis-
tribution into the markets without apposite quality assur-
ance of the finished cosmetic products [2, 10, 15, 16]. 
Such contamination in the cosmetics items may result 
in several diseases including scabies, acne, eczema, dys-
chromia and other skin diseases [8, 17–21].
Like the pharmaceutical products, cosmetics are quite 
likely to consist of various substrates as the product 
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ingredients which in turn may unfortunately further sup-
port the growth of a range of pathogenic bacteria and 
fungi [3, 9]. Therefore, these health care products need 
to be free from pathogens to reduce the possibility of 
the impairment of skin and mucous membranes [3, 17]. 
The incidence of skin diseases is likely to be frequent in 
the developing countries due to the unhygienic environ-
ment, dense population favoring contagious diseases, 
lack of awareness on cleanliness, improper sanitation 
practices, and finally the massive use of contaminated 
processing water [22–26]. Hence this is imperative that a 
proper maintenance of sound microbiological quality of 
the cosmetic products’ manufacturing starting from raw 
materials as well as the manufacturing waters accord-
ing to the guidelines stated in the Good Manufacturing 
Practice (GMP) and the Food and Drug Administration 
(FDA) is stringently required (Fig. 1) [27–31]. Indeed, the 
clear understanding the requirement of microbiological 
analyses of raw materials and final products of cosmetics 
for obtaining products with good microbiological qual-
ity in accordance to the microbial limit recommended 
in the British Pharmacopeia (BP), United States Pharma-
copeia (USP) or the European Pharmacopeia (EP) and 
other regulatory bodies is thus essential, too [30–34]. 
Pharmaceutical and cosmetic industries in Bangladesh 
have been expanding for the last two decades with a great 
scope of maintenance of public health safety and the 
associated business as well [35]. Unlike the pharmaceuti-
cal medicaments, the foremost health concern relies on 
the lack of cosmetic testing aptitudes as well as the inad-
equate facilities in the poor settings, like in Bangladesh 
[2]. Since a large number of users are dependent on the 
various cosmetic items, it is of essence to visualize the 
extent of microbial contamination within these products 
as has been rationalized above. Along this line, the pre-
sent review discusses the frequency and type of micro-
biological contamination of the commonly used cosmetic 
products in Bangladesh and focuses on the prevalence of 
health deteriorating pathogenic bacteria in terms of pub-
lic health issues.
Review
Microorganisms associated with the cosmetic items: global 
and Bangladeshi perspectives
Contamination of cosmetic products by an array of 
pathogenic bacteria like Staphylococcus aureus, Pseu-
domonas aeruginosa, Streptococcus spp., Micrococcus 
spp., Clostridium tetani, Bacillus cereus, actinomycetes 
and fungi has been reported worldwide; however, as 
stated earlier, such knowledge is scarce in Bangladesh 
[10, 13, 14]. Until recently, Bangladeshi scientific com-
munity remains quite reluctant about cosmetic microbi-
ology; very interestingly, microbiological contamination 
aspects were resolved almost 30  years ago. In 1946, the 
first notification of microbial contamination was made in 
talcum powder by Clostridium tetani, and then in 1967, 
Klebsiella pneumoniae was reported to contaminate hand 
creams, and finally in 1983, aqueous soaps were observed 
to harbor Pseudomonas stutzeri [30]. The principal rea-
sons behind such contamination has been chalked out 
afterwards, and the microbiological experiments demon-
strated that the unhygienic handling of bulk ingredients 
during manufacturing followed by the insufficient in-pro-
cess check principally account for such contamination 
[2, 36–39]. However, certain acceptable limits of micro-
organisms within the cosmetic items have been recom-
mended by the FDA and BP/USP. For example, in case 
of cosmetic items to be applied within the non-eye area, 
the Total Aerobic Microbial Count (TAMC) should be 
no more than 103 cfu g−1; and for the items used within 
the eye area, the limit should not exceed 102 cfu g−1 [1, 8, 
18]. The microbial burden over the recommended limit 
may result in several types of diseases as described above 
[7–20].
Microbial access into the production stream of cos-
metic manufacturing as in pharmaceuticals is very likely 
to occur with a nearly similar mechanism [40]. Common 
microorganisms gaining access into the products and 
premises may include several Gram-negative and Gram-
positive bacteria and the opportunistic pathogens [32]. 
Such contaminants may possess the potential of adapting 
to the ingredients within the products and may survive 
[41]. Microbial contaminants may be sourced from the 
poor quality raw ingredients, manufacturing equipments, 
processing environment and personnel, even within the 
packaging materials [12, 32, 42, 43]. Indeed, the microbial 
contamination of the products kept in market for sales 
purpose is also possible even after all in-process checks 
during manufacturing and packaging, possibly due to 
the (1) microbiological entry into the active ingredients 
or the additives (i.e., preservatives) which remained un-
noticed; (2) due to the improper handling and discrep-
ancy in the storage conditions of the products (Fig. 1).
In Bangladesh, the microbiological contamination 
of the pharmaceutical medicaments has widely been 
reported locally so far [44–48]. However, reports on the 
cosmetic products quality are not that much available 
like the pharmaceutical ones [2, 49–51]. Tests for fin-
ished cosmetic products have been conducted principally 
by a group of researchers employing the recommended 
microbiological and biochemical tests [31, 44–54]. Varie-
ties of soaps, shampoo, lotions, face washes, creams and 
petroleum jelly, whereby almost all samples were found 
to be hugely contaminated with bacteria and fungi (Addi-
tional file 1). The TAMC was noticed to be within a range 
of 103–105 cfu  g−1 whereas the Total Yeast and Mould 
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Count (TYMC) was observed up to 103 cfu g−1. Samples 
were found to harbor several pathogenic bacteria; i.e., 
Staphylococcus spp., Pseudomonas spp. and Bacillus spp. 
within a range of 101–103 cfu g−1. Presence of Klebsiella 
spp. was also noted up to 101 cfu g−1. In a recent study, 
among 10 categories of samples (total 30 items), almost 
all samples were found to possess the TAMC and TYMC 
up to 105 cfu  g−1 and 103 cfu  g−1, respectively [49]. 
Growth of Staphylococcus spp., Pseudomonas spp. and 
Klebsiella spp. was also noted. Taken together, the micro-
biological survey on a total of 50 items of cosmetic prod-
ucts revealed the microbial load in an unsafe level which 
further leads to greater public health risk associated prin-
cipally with skin diseases among the users. For maintain-
ing the sustainable quality of the cosmetic products, as 
for pharmaceuticals, the widely implemented concept 
of Hazard Analysis of Critical Control Points (HACCP) 
can be employed to improve the microbiological safety 
Fig. 1 Regulatory scheme for maintenance of the microbiological quality of cosmetic products. The figure illustrates the possible microbiological 
entry into the cosmetics products. The microbial load should be examined at every stage of manufacturing and packaging till the finished product 
formation, and should be intermittently checked during storage and distribution. The bio-burden is required to meet the specification criteria as 
recommended by the British Pharmacopeia (BP), European Pharmacopeia (EP) or the United States Pharmacopeia (USP). Market complaints need 
to be handled carefully to ensure the further product quality employing the good manufacturing practice (GMP) and total quality management 
(TQM). The critical points of microbial access into the products are required to be monitored by means of the “hazard analysis: critical control point” 
(HACCP) implementation [51]
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of the finished products [31, 32, 55]. Interestingly, with 
an opposite trait to microbiological proliferation within 
the cosmetic items, the anti-bacterial activity was 
observed in seven samples against Staphylococcus spp., 
E. coli, Bacillus spp., Pseudomonas spp., Klebsiella spp. 
and Listeria spp. employing the methods described ear-
lier [56–58]. Besides the microbiological contamination 
aspect of the cosmetics products, such anti-bacterial 
trait of these items may, in contrary, draw an overall pub-
lic health impact of the cosmetic samples tested. Over-
all, the microbiological investigation on the commonly 
used cosmetic revealed a huge microbial contamination 
exceeding the recommended limits. Stern actions on the 
microbiological quality control along with the personal 
hygienic improvement during cosmetic products pro-
cessing would be effective for the enhanced management 
of the mass public health.
Recommendations
Although the microbial analysis of the cosmetic prod-
ucts described above has been done in small scale, still 
the sample size of 50 was quite enough to indicate valid 
results on the current microbiological status of the prod-
ucts in context to project microbiological management 
of cosmetic products in Bangladesh. However, routine 
microbiological tests of all cosmetic items sold in market 
are required, and the necessary steps should be taken by 
Bangladeshi Government, too. Besides the regular tests 
of the finished products by the cosmetic manufacturing 
industries, additional quality tests of the market items 
can be initiated by the universities and research organiza-
tions in Bangladesh, thereby raising the firmness of qual-
ity of the sold products among the users.
Another vital problem is that in many cases cosmetic 
oriented skin irritations that are noticed within Bang-
ladeshi people remain undiagnosed [59]. Appropriate 
diagnosis of the diseases caused by cosmetic is definitely 
required. Furthermore, as many drug oriented diseases 
are also emerging within the Bangladeshi community 
mostly due to the microbial drug-resistance traits as well 
as the microbial contamination of finished products, 
appropriate microbiological analyses are required not 
only for disease diagnosis or the pharmaceutical product 
quality, but also for the sound formation of the finished 
forms of the cosmetic products [51]. Besides, rigorous 
measures need to be taken by the Bangladeshi legisla-
tive bodies to ensure the practice and commencement of 
GMP maintenance in the cosmetic manufacturing indus-
tries. The operational sites must comply with the FDA 
requirements and appropriate quality assurance (QA) 
system must be endorsed during the market survey mar-
ket complaints.
The manufacturing and packaging processes of the 
cosmetic items should be strictly maintained by specifi-
cations given by the Federal Food, Drug and Cosmetic 
Act (FD and C Act) and the Fair Packaging and Labe-
ling Act (FPLA) [60]. Regular inspection of cosmetic 
manufacturing facilities  is required to assure cosmetic 
product safety and to determine whether cosmetics are 
adulterated or misbranded under the FD & C Act or 
FPLA. According to the International Standard Organi-
zation (ISO) 22716 and FDA regulations, building 
premises, constructions and facilities used for manufac-
turing of cosmetic products should have adequate space 
together with built-in outfit to prevent cross contamina-
tion between raw materials, intermediate formulations, 
bulk materials and finished products. Periodic control 
of pests, sufficient lighting and ventilation, filtering of 
dust particles, maintenance of pharmaceutically ambi-
ent humidity and temperature, and frequent sanitary 
safeguarding in the manufacturing areas are worth to 
implement. All equipments should be maintained in 
clean conditions with regular calibration, and should be 
of defined design, size, and material in order to prevent 
particle droplet and microbial adhesion [61]. Thorough 
cleaning of containers and the hygiene of the work-
ers along the production line should be accomplished 
according to the international and/or European laws and 
legislations. Together with regular microbiological tests 
(microbial limit tests, sterility tests, microscopy, etc.), 
the raw materials should be stored in closed containers 
and handled carefully to prevent mix-ups or selection 
errors, contamination with microorganisms or other 
chemicals, and degradation from exposure to excessive 
heat, cold, sunlight, moisture, etc. [61]. The entire sys-
tem for the manufacturing water should be routinely 
monitored for the presence of pyrogens, and should be 
free from the possible development of biofilm. Another 
point is to ponder over the use of color additives in cos-
metic items. When used in cosmetics, they must comply 
with the identity, specifications, uses, restrictions, and 
labeling requirements stated in the FD and C Act [62].
People in the cosmetic stores responsible for mainte-
nance and sales of the finished products should be aware 
of keeping the storage conditions at the required level 
(for instance, at appropriate temperatures and humid-
ity). The regulatory bodies both within the Governmental 
and the private sectors should take appropriate meas-
ures in coordination with the microbiology researchers, 
pharmacy professionals and the physicians around the 
country. Overall, as a number of diseases are emerging in 
Bangladesh, the appropriate handling of cosmetic prod-
ucts would definitely aid in reducing the ongoing com-
mon diseases [51, 63, 64].
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Conclusion
Pharmaceutical industries in Bangladesh are abundant 
and a number of pharmaceutical medicaments are avail-
able while some are imported from foreign pharmaceuti-
cal manufacturers. In contrast, cosmetic manufacturing 
industries in Bangladesh are very few, and as a result, 
plenty of cosmetic items are imported in Bangladesh. The 
laboratory based microbiological analyses of the pharma-
ceutical medicaments are in plenty in Bangladesh; how-
ever, such in  vitro experiments on the cosmetic items 
are in scarce. Present review portrayed the informative 
description on the common cosmetic items in Bangla-
desh along with their microbiological status in accord-
ance with the recommended limit by the international 
regulatory bodies. The laboratory investigations in small 
scale as described in this article unraveled that a major 
portion of cosmetic products might be contaminated 
with pathogenic microorganisms. Such public health 
concern should be addressed stringently, not only in 
Bangladesh perspective, but also within the other devel-
oping countries consisting of people mostly unconscious 
about the negative impact of the usage of cosmetics.
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